Position in BHVN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$255,936
New position
Shares Held
17,200
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#180
of 294 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Almanack Investment Partners, LLC. holds $2,305,722 across 11 Biotechnology names. BHVN ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HYPD |
Hyperion Defi, Inc.
|
169,013 | $530,700 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
649 | $404,677 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
|
44,950 | $306,109 | |
| 4 | BHVN |
Biohaven Ltd.
This page
|
17,200 | $255,936 | |
| 5 | MRNA |
Moderna, Inc.
|
3,194 | $223,675 | |
| 6 | RGNX |
REGENXBIO Inc.
|
13,955 | $167,180 | |
| 7 | DTIL |
Precision Biosciences Inc
|
20,428 | $160,564 | |
| 8 | TNYA |
Tenaya Therapeutics, Inc.
|
168,200 | $124,299 |
All Filings in BHVN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $255,936 | 17,200 | Shares | Sole | 2026-07-30 | |
| No filing history on record for this holder in this stock. | ||||||